Skip links

Search By Condition or Specialty.


Full Name JAYTHARI (deflazacort)
Drug deflazacort (tablet and oral suspension)
Manufacturer Zydus Lifesciences Limited
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology; Genetics
Enrollment Form Link Enrollment Form
Phone Number (847) 393-4099
Fax Number (877) 860-1978
Product Website jaythari.com
Patient Resources Alex Rezcalla FoundationJett Foundation, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy